By contrast, decreased dopamine levels (as in Parkinson’s Disease) result in a marked pruning of the MSN spine density, but also a decrease of glutamatergic synapses onto D2 dopamine receptor (D2R)-expressing MSNs (Day et al., 2006; Deutch et al., 2007). The gene discussed is DRD2; the disease is Parkinson disease.